Czechia is switching to a pharmaceutical cost group (GCP) model, which will allow capitation payment to be risk-adjusted for patients with chronic diseases. The move, originally scheduled for 2017, is deferred to 2018.
Sources close to the Western European diagnostics chain say JP Morgan and Goldman Sachs are in the process of raising the money to allow Synlabs to buy Unilabs in a deal valued at €1.5bn. And what about French reference lab Cerba, which PAI plans to sell before Christmas?
UK-based roadtohealth, which owns and manages the chronic disease predictor and wellness app Quealth, has attracted US$4m of investment from the American insurer Reinsurance Group of America (RGA).
The potential for wound care clinics – especially in emerging markets – is huge. Often costing little to set up, the opportunity to cut costs, cut average length of stay, and operate a quick turnaround (ideally from private payors) should be appealing. So why aren’t we seeing more of them? Healthcare Nova speaks to Rafael Mazuz, MD of OliveSeraph which advises providers how to make such clinics work.
Sereni Orizzonti, which claims to be Italy’s third largest care home construction and management chain, wants to strengthen its presence in southern Italy –and build ten new facilities across Italy in the next five years.
In March, we examined a report by the OECD on the affordability of private hospitals in South Africa, and gave space to experts on either side of the debate to discuss the findings. We’re now giving the final author of the report, Tomas Roubal, an economist at the World Health Organisation (WHO), an opportunity to enter the debate after he presented his findings at the Board of Healthcare Funders conference this summer.
Russian conglomerate Sistema is one of two investors competing to buy up to 51% of a new hospital in the Moscow region for an estimated €11m, according to local reports.
Sila Grup, which is a Turkish operator and consultancy, is reported to have signed an MoU with the Iranian Ministry of Health to invest US$1bn in the country.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
